Immunic Inc (NASDAQ:IMUX) will participate in key scientific and industry conferences in April 2025.
From April 5-9, company representatives will attend the American Academy of Neurology (AAN) Annual Meeting in San Diego at booth #2233.
On April 9-10, Chief Scientific Officer Hella Kohlhof, Ph.D., will present at German Biotech Days (DBT 2025) in Heidelberg, discussing vidofludimus calcium (IMU-838).
The presentation will be available on Immunic’s website.